Vera Therapeutics (VERA) Short-term Investments (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Short-term Investments data on file, last reported at $482.4 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 9.79% year-over-year to $482.4 million; the trailing twelve-month figure through Mar 2026 stood at $482.4 million (down 9.79% YoY), and the FY2025 full-year result was $359.9 million, down 34.36% from the prior year.
• Short-term Investments for Q1 2026 stood at $482.4 million, up from $359.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $548.2 million in Q4 2024 and bottomed at $39.4 million in Q1 2022.
• The 5-year median for Short-term Investments is $326.1 million (2024), against an average of $271.9 million.
• The widest annual swing landed in 2022, when Short-term Investments jumped 162902.0%; it then tumbled 34.36% in 2025.
• A 5-year view of Short-term Investments shows it stood at $71.2 million in 2022, then jumped by 61.58% to $115.0 million in 2023, then jumped by 376.56% to $548.2 million in 2024, then sank by 34.36% to $359.9 million in 2025, then soared by 34.05% to $482.4 million in 2026.
• The last three Short-term Investments figures came in at $482.4 million (Q1 2026), $359.9 million (Q4 2025), and $439.6 million (Q3 2025), per Business Quant data.

Peer Comparison